Learn more about our Legal work.
This case involves a patent infringement dispute between EcoFactor and Google, but the Court’s decision will reach every aspect of district court patent litigation in cases involving parties in every…
The issue at hand is patent infringement and an overly broad interpretation of the Hatch-Waxman Act’s safe harbor. AdvaMed pointed out that this would harm innovation. The decision has profound…
The case arises from Gilead Sciences’ successful HIV/AIDS drug, tenofovir disoproxil fumarate (TDF). Plaintiffs allege injury from TDF but do not allege any defect with the design, manufacture, marketing, or…
Relator was contending that commission-based contract sales arrangements are per se violations of the AKS. AdvaMed noted that this suit is the first time a plaintiff has alleged that a…
The case involved expansive Biometric Privacy Act (BIPA) liability for medical device manufacturers. The device at issue was a medstation manufactured by BD that stores patient pharmaceuticals that can be…
AdvaMed filed an amicus brief in the case of Smith v. Terumo BCT, Inc. The case concerns whether the court should create a cause of action for asymptomatic plaintiffs, permitting…
AdvaMed’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical…